PB2110: PHARMACOKINETICS AND PHARMACODYNAMICS IN FIRST-MIND: A PHASE IB, OPEN-LABEL, RANDOMIZED STUDY OF TAFASITAMAB ± LENALIDOMIDE + R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA
HemaSphere | June 24, 2022 | Volume: 6 | Issue: No issue available | Pages: 1981-1982
10.1097/01.hs9.0000851272.68157.fc